GT BIOPHARMA INC (GTBP) Stock Balance Sheet
NASDAQ:GTBP - Nasdaq - US36254L3087 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.42M | 3.95M | 1.08M | 5.67M | 8.97M | |||
| Marketable Securities | N/A | N/A | 12.89M | 10.84M | 23.01M | |||
| Other Current Assets | 341.00K | 281.00K | 84.00K | 54.00K | 190.00K | |||
| Total Current Assets | 6.76M | 4.23M | 14.06M | 16.56M | 32.17M | |||
| Non-Current Assets | ||||||||
| PPE Net | 0.00 | 0.00 | 53.00K | 165.00K | N/A | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | N/A | N/A | N/A | 9.00K | N/A | |||
| Total Non-Current Assets | 0.00 | 0.00 | 53.00K | 174.00K | 0.00 | |||
| TOTAL ASSETS | 6.76M | 4.23M | 14.11M | 16.74M | 32.17M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 31.00K | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | 0.00 | |||
| Accrued Expenses | 1.87M | 1.80M | 1.25M | 1.78M | 1.90M | |||
| Accounts Payable | 2.61M | 3.85M | 4.33M | 3.14M | 8.19M | |||
| Other Current Liabilities | 182.00K | 252.00K | 1.05M | 19.00K | 138.00K | |||
| Total Current Liabilities | 4.66M | 5.90M | 6.63M | 4.94M | 10.26M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | N/A | N/A | N/A | 64.00K | N/A | |||
| Total Non-Current Liabilities | 0.00 | 0.00 | 0.00 | 64.00K | 0.00 | |||
| TOTAL LIABILITIES | 4.66M | 5.90M | 6.63M | 5.00M | 10.26M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -691.45M | -695.23M | -682.07M | -674.47M | -653.58M | |||
| Additional Paid In Capital | 693.55M | 693.55M | 689.54M | 686.17M | 674.35M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 3.00K | 3.00K | 2.00K | 34.00K | 1.15M | |||
| Shares Outstanding | 2.23M | 2.23M | 1.38M | 1.09M | 1.07M | |||
| Tangible Book Value per Share | 0.94 | -0.75 | 5.41 | 10.75 | 20.49 | |||
| Total Shareholders' Equity | 2.10M | -1.67M | 7.48M | 11.73M | 21.91M | |||
| TOTAL LIABILITIES AND EQUITY | 6.76M | 4.23M | 14.11M | 16.74M | 32.17M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 1.45 | 0.72 | 2.12 | 3.35 | 3.14 | |||
| Return On Assets (ROA) | -182.70% | -311.01% | -53.85% | -124.78% | -180.34% | |||
| Return On Equity (ROE) | -588.89% | N/A | -101.62% | -177.98% | -264.78% | |||
All data in USD , ROIC based on taxRate of 0.21